Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with Intellectual Disability
2011

Genetic Variability of ASMT in Patients with Intellectual Disability

Sample size: 801 publication 10 minutes Evidence: moderate

Author Information

Author(s): Cecile Pagan, Botros Hany Goubran, Karine Poirier, Anne Dumaine, Stéphane Jamain, Sarah Moreno, Arjan de Brouwer, Hilde Van Esch, Richard Delorme, Jean-Marie Launay, Andreas Tzschach, Vera Kalscheuer, Didier Lacombe, Sylvain Briault, Frédéric Laumonnier, Martine Raynaud, Bregje W van Bon, Marjolein H Willemsen, Marion Leboyer, Jamel Chelly, Thomas Bourgeron

Primary Institution: Institut Pasteur, Paris, France

Hypothesis

Patients with intellectual disability may carry deleterious ASMT mutations that act as risk factors for sleep and circadian disorders.

Conclusion

The study identified patients with deleterious ASMT mutations and decreased ASMT activity, but did not find significant enrichment of ASMT variants in patients with intellectual disability compared to controls.

Supporting Evidence

  • Eleven variations modifying the protein sequence of ASMT were identified.
  • Two deleterious splice site mutations were found only in patients with ID.
  • ASMT activity was significantly lower in patients carrying mutations compared to controls.

Takeaway

Some kids with intellectual disabilities might have problems making a chemical called melatonin, which helps them sleep, but this study didn't find enough evidence to say that a specific gene is the cause.

Methodology

Sequenced all exons of ASMT in 361 patients with intellectual disability and 440 controls, measuring ASMT activity in B lymphoblastoid cell lines.

Potential Biases

The study population may not represent the broader diversity of patients with intellectual disability.

Limitations

The patient sample was biased towards X-linked ID and lacked comprehensive data on sleep disorders.

Participant Demographics

Patients were primarily of European ancestry, with 361 male patients and 440 unrelated healthy controls.

Statistical Information

P-Value

0.004

Statistical Significance

p = 0.004

Digital Object Identifier (DOI)

10.1186/1471-2350-12-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication